Elucidating the exact pharmacological system of action (MOA) of naturally developing compounds might be challenging. While Tarselli et al. (sixty) designed the initial de novo artificial pathway to conolidine and showcased that this naturally taking place compound successfully suppresses responses to the two chemically induced and inflammation-deri